Anti-tumor abilities of IL-13 cytotoxins have been shown in vivo, particularly in IL-13Rα2-positive pancreatic cancer cell lines, and also in animal models of human pancreatic cancer [100,108,110]. This evidence concerns the gene IL13 and neoplasm.